Common Hawthorn is a gentle, well-tolerated heart botanical, used as a standardized leaf-and-flower extract. Its strongest evidence supports easing symptoms and improving exercise ability in mild, early heart weakness. Effects on blood pressure, cholesterol, lifespan, and major heart events remain weak or unproven. The main caution is overlap with heart and blood-pressure medicines. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood pressure | ~110–125 / 70–80 mmHg | Detects additive hypotension and tracks any vascular benefit |
| Resting heart rate | 55–70 bpm | Screens for additive effects on rate/rhythm |
| Exercise tolerance (functional capacity) | Improvement over baseline | Primary success marker in mild heart failure |
| NT-proBNP | Trending down or stable, ideally <125 pg/mL | Reflects cardiac wall stress in heart failure |
| Left ventricular ejection fraction | ≥55% (or stable/improved) | Tracks pumping efficiency if heart failure is present |
| Lipid panel | TC <200; HDL >50; TG <100 mg/dL | Assesses any modest lipid effect |
| Digoxin level (if co-administered) | 0.5–0.9 ng/mL | Guards against additive glycoside effect |
| eGFR (kidney function) | >60 mL/min/1.73m² | Contextualizes cardiac markers and drug clearance |
Cadence: Baseline check, reassess at 6–12 weeks to judge response and tolerability, then every 6–12 months; more frequent blood-pressure checks in the first weeks if combined with antihypertensives.